Yes, page-21

Investors warn Australian startups working on the forefront of medical research could be pushed to the brink as the coronavirus outbreak puts a squeeze on capital.

"Companies that move quickly now are likely to survive, but there will be lots of layoffs," said Chris Nave, managing director of biomedical investment firm Brandon Capital Partners.

From today's Sydney Morning Herald. Despite the obvious short term discomfort for some regarding dilution I would rather have my money in a well financed operation that has the funds to capitalise and advance their first in the world programme.